Why now: the FDA comment deadline is weeks away
Meta-analyses including over 40,000 individuals demonstrate a decreased risk of composite renal outcomes (HR 0.79, 95% CI 0.720.87), confirming renal protection as a class effect independent of cardiovascular advantages (Mavrakanas et al
Stacking appetite suppressants with a GLP-1 can increase the risk of side effects like nausea, shakiness and undereating, Zerner says
Tirzepatide is a peptide therapy used to treat insulin resistance, Type 2 diabetes, and support weight management
Yes, National Guard and Reserve members often have more flexibility, especially when not on active-duty orders
NHS Coverage vs Private Prescribing for Obesity Medicines NHS access to weight management medicines requires NICE approval and eligibility criteria